The Medicines Company (MDCO -1.5%) says it's formed an exclusive global alliance with Alnylam...

|About: The Medicines Company (MDCO)|By:, SA News Editor

The Medicines Company (MDCO -1.5%) says it's formed an exclusive global alliance with Alnylam Pharmaceuticals (ALNY -2.6%) for the development and commercialization of ALNY's ALN-PCS RNAi therapeutic program for the treatment of hypercholesterolemia. The deal could net ALNY $205M plus double-digit royalties if the collaboration is successful, and an early-stage trial has already showed success.